of
LEXINGTON, Ky. (April 12, 2021) With COVID-19 vaccinations continuing to roll out across the country, the University of Kentucky Markey Cancer Center strongly encourages both cancer survivors, caregivers and patients in active cancer treatment to receive one of the available vaccines. This is in line with recommendations from both the Centers for Disease Control and Prevention (CDC) and the American Cancer Society.
As of Monday, April 5, any Kentuckian age 16 and up is eligible to get the Pfizer vaccine. The Moderna and Johnson & Johnson vaccines are available to anyone age 18 and older. Given the higher rates of severe COVID-19 infection in cancer patients, the American Society of Clinical Oncology and the CDC recommend that cancer patients strongly consider vaccination against COVID-19, said Dr. Frederick R. Ueland, gynecologic oncologist and director of oncology clinical operations at the UK Markey Cancer Center. This includes cancer survivors, most patients undergo
of
LEXINGTON, Ky. (Feb. 19, 2021)
– After conducting a study to assess the need for cancer education materials in Appalachian Kentucky, members of the University of Kentucky Markey Cancer Center’s Appalachian Career Training in Oncology (ACTION) program worked with faculty from the UK College of Education to create a three-part cancer education curriculum for middle and high school teachers in the region.
Kentucky is home to the highest rates of cancer incidence and mortality in the country, and that problem is further concentrated in the Appalachian region of the state. Funded by a grant from the National Cancer Institute, ACTION is a two-year program designed to prepare undergraduate and high school students for cancer-focused careers and is open to students who hail from one of the 54 Appalachian Kentucky counties. The program also educates students on ways to make a difference in their own communities through outreach and engagement.
Markey joined a coalition of 76 cancer centers and national organizations to encourage Americans to stay on track with cancer screenings and treatment during the pandemic.
LEXINGTON, Ky. (Jan. 29, 2021) The University of Kentucky Markey Cancer Center is teaming up with the National Comprehensive Cancer Network® (NCCN®), the American Cancer Society (ACS) and other leading cancer organizations across the country to endorse the resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.
The coalition of 76 organizations has released an open letter reminding the public that cancer still poses a major threat to people’s health, but acting as soon as is safely possible can lead to much better outcomes in the future. The letter examines distressing trends showing a significant drop-off in recommended cancer screening and treatment compared to prior years. This concerning side-effect of the pandemic could lead to a staggering number of preventable cancer death
of
LEXINGTON, Ky. (Jan. 28, 2021) UK HealthCare, home to the University of Kentucky Markey Cancer Center, has officially been recognized as a System of Excellence for Hidden Scar breast cancer surgery, the highest level of Hidden Scar designation. UK HealthCare is the first and only hospital system in Kentucky to be certified as a Hidden Scar System of Excellence. This surgical option provides the women of Kentucky with a procedure that effectively treats breast cancer while optimizing cosmetic results.
The American Cancer Society estimates that 3,800 Kentucky women will be diagnosed with breast cancer this year. Of those women, most will need surgery as part of their treatment. Though surgical techniques over the decades have improved, traditional breast cancer surgeries still leave visible scars behind.